Telik (TELK): New Drug Don’t Work
Telik (TELK), biopharmaceutical company, is off almost 25% today on news that the FDA has stopped research on its ovarian cancer drug Telcyta.Stating the obvious, Wachovia said: "Anticipating significant shareholder ...Read Full Story »

